Gelonghui, Feb. 28, 丨 An Xu Biotech (688075.SH) announced its 2023 annual performance report. During the reporting period, the company achieved operating income of 508.2998 million yuan, a decrease of 91.76% over the same period of the previous year; realized net profit attributable to owners of the parent company of 141.7741 million yuan, a decrease of 95.34% over the same period last year; realized net profit attributable to owners of the parent company after deducting non-recurring profit and loss of 52.44,800 yuan, a decrease of 98.24% from the same period last year.
安旭生物(688075.SH)：2023年净利润同比下降95.34%
Anxu Biotech (688075.SH): Net profit in 2023 fell 95.34% year on year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.